Sort
23,748 grants matching “melanoma”
PEG-Prom Mediated Theranostics for Prostate Cancer
$235,449Martin G Pomper · Johns Hopkins University · P50 · FY2017 · CA
Control of Eye Melanoma Metastsis
$235,389Hans E Grossniklaus · Emory University · R01 · FY2006 · CA
STATs as a Novel Approach to Cancer Therapy
$235,295James K Turkson · University Of Central Florida · R01 · FY2007 · CA
STATs as a Novel Approach to Cancer Therapy
$235,295James K Turkson · University Of Central Florida · R01 · FY2008 · CA
STATs as a Novel Approach to Cancer Therapy
$235,295James K Turkson · University Of Central Florida · R01 · FY2009 · CA
Plasmacytoid Dendritic Cells in Anti-Tumor Response
$235,288Marco Colonna · Washington University · R01 · FY2006 · CA
Interrogating the role of GTP metabolism in Rac1-driven phenotypes in melanoma
$235,281David W Wolff · Augusta University · R00 · FY2025 · CA
Tumor microvesicle-mediated modulation of the bone microenvironment
$235,093Evan Todd Keller · University Of Michigan At Ann Arbor · P01 · FY2016 · CA
Targeting the B Cell Receptor Signaling Network in Lymphoma
$235,049Jonathan Michael Irish · Vanderbilt University · R00 · FY2014 · CA
Enhancing Melanoma TIL Efficacy with Multifactor mRNA-Mediated T Cell Reprogramming
$234,919Samuel G Katz · Yale University · R21 · FY2023 · CA
Molecular Imaging of Cancer In vivo via Targeted Transduction
$234,840Irvin S.y. Chen · University Of California Los Angeles · R01 · FY2007 · CA
Molecular Imaging of Cancer In vivo via Targeted Transduction
$234,840Irvin S.y. Chen · University Of California Los Angeles · R01 · FY2008 · CA
CNS Anti-tumor immunity induced by dendritic cell vaccination and TLR agonists
$234,840Robert M Prins · University Of California Los Angeles · R01 · FY2007 · CA
CNS Anti-tumor immunity induced by dendritic cell vaccination and TLR agonists
$234,840Robert M Prins · University Of California Los Angeles · R01 · FY2009 · CA
CNS Anti-tumor immunity induced by dendritic cell vaccination and TLR agonists
$234,840Robert M Prins · University Of California Los Angeles · R01 · FY2008 · CA
Molecular Imaging of Cancer In vivo via Targeted Transduction
$234,840Irvin S.y. Chen · University Of California Los Angeles · R01 · FY2009 · CA
CNS Anti-tumor immunity induced by dendritic cell vaccination and TLR agonists
$234,840Robert M Prins · University Of California Los Angeles · R01 · FY2010 · CA
Project 3: Mechanism-Based Design ofCombination Therapies for Pancreatic Cancer
$234,824Tayyaba Hasan · Massachusetts General Hospital · P01 · FY2015 · CA
Systemic/Abscopal Anti-Tumor Immune Responses during IAP Antagonism and Radiation
$234,750Nicole Cherie Schmitt · Emory University · R21 · FY2025 · DE
In-Clinic Latanoprost As a Novel Vaccine Adjuvant
$234,750Zhaoyang You · University Of Pittsburgh At Pittsburgh · R21 · FY2021 · AI
SPORE: Targeted Therapies for Glioma
$234,721Tracy T Batchelor · Brigham And Women'S Hospital · P50 · FY2023 · CA
Core B - Biospecimen/Pathology Core
$234,665Iman Osman · New York University School Of Medicine · P50 · FY2023 · CA
Autoimmune vitiligo as a roadmap to melanoma therapy
$234,630Loyola University Chicago · R01 · FY2005 · CA
NIAMS - Research Training in Dermatology
$234,597Richard L Edelson · Yale University · T32 · FY2006 · AR
OVARIAN CANCER MESOTHELIN ANIMAL MODEL/DNA VACCINES
$234,577T.-C. Wu · Johns Hopkins University · U19 · FY2009 · CA